首站-论文投稿智能助手
典型文献
Duration of acute kidney injury predicts 90-day mortality and chronic kidney disease progression in elderly patients
文献摘要:
Background::This study evaluated the prognostic impact of acute kidney injury (AKI) duration on 90-d mortality and new-onset chronic kidney disease (CKD) progression in elderly patients.Methods::We retrospectively enrolled elderly patients (≥75 years; n = 693) from the Chinese PLA General Hospital between January 1, 2007 and December 31, 2018. The 2012 Kidney Disease Improving Global Outcomes (KDIGO) defined serum creatinine (Scr) criteria were used to identify and classify AKI. Patients were divided into transient AKI (T-AKI) and persistent AKI (P-AKI) groups based on whether Scr levels returned to baseline within 48 h post-AKI. We further classified P-AKI based on AKI duration: (1) short duration: resolving AKI lasting 3-4 days; (2) medium duration: resolving AKI lasting 5-7 days; and (3) long duration: AKI lasting >7 days. Results::Among patients, 62 (9.0%) had T-AKI (1-2 days), 104 (15.0%) had short-duration, 140 (20.2%) had medium-duration, and 387 (55.8%) had long-duration. In total, 209 (30.2%) died within 90 days; 122 (25.2%) developed CKD. After adjusting for multiple covariates, duration of AKI (3-4 days: hazard ratio [HR] = 2.512; P =0.045; 5-7 days: HR=3.154; P =0.015; >7 days: HR=6.212; P<0.001) was significantly associated with a higher 90-day mortality. Longer AKI duration (3-4 days: odds ratio [OR] = 0.982; P =0.980; 5-7 days: OR=1.322; P =0.661; >7 days: OR=7.007; P<0.001) was significantly associated with new-onset CKD of survivors. Conclusion::AKI duration is useful for predicting poorer clinical outcomes in elderly patients, emphasizing the importance of identifying an appropriate treatment window for early intervention.
文献关键词:
Acute kidney injury;Duration;Elderly;Mortality;Renal function
作者姓名:
Li Qinglin;Li Yuru;Zhou Feihu
作者机构:
Department of Critical Care Medicine, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China;Department of Laboratory Test, The Second Medical Center, Chinese PLA General Hospital, Beijing 100853, China;Chinese PLA General Hospital National Clinical Research Center for Geriatric Diseases, Beijing 100853, China
引用格式:
[1]Li Qinglin;Li Yuru;Zhou Feihu-.Duration of acute kidney injury predicts 90-day mortality and chronic kidney disease progression in elderly patients)[J].重症医学(英文),2022(02):110-117
A类:
B类:
Duration,acute,kidney,injury,predicts,mortality,chronic,disease,progression,elderly,patients,Background,This,study,evaluated,prognostic,impact,AKI,duration,new,onset,CKD,Methods,We,retrospectively,enrolled,years,from,Chinese,PLA,General,Hospital,between,January,December,Kidney,Disease,Improving,Global,Outcomes,KDIGO,defined,serum,creatinine,Scr,criteria,were,used,classify,Patients,divided,into,transient,persistent,groups,whether,levels,returned,baseline,within,post,further,classified,short,resolving,lasting,days,medium,long,Results,Among,had,In,total,died,developed,After,adjusting,multiple,covariates,hazard,was,significantly,associated,higher,Longer,odds,survivors,Conclusion,useful,predicting,poorer,clinical,outcomes,emphasizing,importance,identifying,appropriate,treatment,window,early,intervention,Acute,Elderly,Mortality,Renal,function
AB值:
0.536414
相似文献
Treatment patterns and a prognostic scoring system for elderly acute myeloid leukemia patients: a retrospective multicenter cohort study in China
Chunli Zhang;Wei Wan;Shuai Zhang;Jingwen Wang;Ru Feng;Jiangtao Li;Junyue Chai;Hebing Zhou;Liru Wang;Yuping Zhong;Xiaodong Mo;Mengzhu Shen;Hongmei Jing;Hui Liu-Department of Hematology,Beijing Hospital,National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing 100730,China;Department of Hematology,Peking University Third Hospital,Beijing 100191,China;Department of Hematology,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China;Department of Hematology,Beijing No.6 Hospital,Beijing 100007,China;Department of Hematology,Beijing Luhe Hospital,Capital Medical University,Beijing 101100,China;Department of Hematology,Fuxing Hospital,Capital Medical University,Beijing 100038,China;Department of Hematology,Beijing Chao-Yang Hospital,Capital Medical University,Beijing 100043,China;Peking University People's Hospital,Peking University Institute of Hematology,National Clinical Research Center for Hematologic Disease,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation,Beijing 100044,China
Efficacy of the herbal formula of Foeniculum vulgare and Rosa damascena on elderly patients with functional constipation:A double-blind randomized controlled trial
Maryam Azimi;Hanieh Niayesh;Mahboobeh Raeiszadeh;Sedigheh Khodabandeh-shahraki-Gastroenterology and Hepatology Research Center,Kerman University of Medical Sciences,Kerman 7716913555,Iran;Department of Traditional Medicine,School of Persian Medicine,Kerman University of Medical Sciences,Kerman 7716913555,Iran;Student Research Committee,Afzalipour Faculty of Medicine,Kerman University of Medical Sciences,Kerman 7716913555,Iran;Herbal and Traditional Medicines Research Center,Kerman University of Medical Sciences,Kerman 7716913555,Iran;Department of Community Health Nursing,Razi Faculty of Nursing and Midwifery,Kerman University of Medical Sciences,Kerman 7716913555,Iran
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
Highly Prevalent SARS-CoV-2 Antigenemia in COVID-19 Patients
Zhang Wenyan;Liu Wei;Lin Jiawang;Jin Jing;Zhao Kefu;Zhu Liwei;Wang Xiuzhen;Wang Lijie;Tang Renshu;Zhu Yindi;Zhou Wei;You Enqing;Zhang Lei;Liu Xuxiang;Wu Jinju;Chen Lili;Wang Wenjing;Zhang Qiang;Gao Rongbao-Hefei Center for Disease Control and Prevention, Hefei, Anhui Province 230061, China;BIOHIT Healthcare (Hefei) Co., Hefei, Anhui Province 230000, China;The First People’s Hospital of Hefei, Hefei, Anhui Province 230091, China;Anhui Provincial Hospital, Hefei, Anhui Province 231501, China;State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China;NHC Key Laboratory of Biosafety, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
Clinical factors associated with composition of lung microbiota and important taxa predicting clinical prognosis in patients with severe community-acquired pneumonia
Sisi Du;Xiaojing Wu;Binbin Li;Yimin Wang;Lianhan Shang;Xu Huang;Yudi Xia;Donghao Yu;Naicong Lu;Zhibo Liu;Chunlei Wang;Xinmeng Liu;Zhujia Xiong;Xiaohui Zou;Binghuai Lu;Yingmei Liu;Qingyuan Zhan;Bin Cao-China-Japan Friendship Hospital,National Clinical Research Center for Respiratory Diseases,National Center for Respiratory Medicine,Clinical Center for Pulmonary Infections,Capital Medical University,Beijing 100029,China;Institute of Respiratory Medicine,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100029,China;Department of Pulmonary and Critical Care Medicine,Center for Respiratory Diseases,China-Japan Friendship Hospital,Beijing 100029,China;Beijing University of Chinese Medicine,Beijing 100029,China;Beijing Luhe Hospital,Beijing 101100,China;Tsinghua University-Peking University Joint Center for Life Sciences,Beijing 100084,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。